{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:36:20Z","timestamp":1790217380060,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Government of Japan Ministry of Education Culture Sports Science and Technology","doi-asserted-by":"publisher","award":["20K09800"],"award-info":[{"award-number":["20K09800"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.oret.2025.05.008","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T19:26:27Z","timestamp":1746818787000},"page":"1062-1070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Risk Factors for Reoperation in Vitrectomy for Stage 4A Retinopathy of Prematurity"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1070-2724","authenticated-orcid":false,"given":"Masaki","family":"Fukushima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0836-5816","authenticated-orcid":false,"given":"Chiharu","family":"Iwahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Kurihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0242-5662","authenticated-orcid":false,"given":"Kazuki","family":"Kuniyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2418-4778","authenticated-orcid":false,"given":"Fukutaro","family":"Mano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8364-0948","authenticated-orcid":false,"given":"Shunji","family":"Kusaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2025.05.008_bib1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.survophthal.2016.12.004","article-title":"Advances in understanding and management of retinopathy of prematurity","volume":"62","author":"Hartnett","year":"2017","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.oret.2025.05.008_bib2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/pr.2013.205","article-title":"Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010","volume":"74","author":"Blencowe","year":"2013","journal-title":"Pediatr Res"},{"key":"10.1016\/j.oret.2025.05.008_bib3","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","article-title":"Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial","volume":"121","author":"Good","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2025.05.008_bib4","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.oret.2025.05.008_bib5","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/IAE.0000000000001241","article-title":"Comparison of intravitreal injection of ranibizumab versus laser therapy for zone II treatment-requiring retinopathy of prematurity","volume":"37","author":"Zhang","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.oret.2025.05.008_bib6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jaapos.2016.09.013","article-title":"Refractive outcomes following the treatment of retinopathy of prematurity in the anti-VEGF era: a literature review","volume":"20","author":"Aghdam","year":"2016","journal-title":"J AAPOS"},{"key":"10.1016\/j.oret.2025.05.008_bib7","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/archophthalmol.2011.1802","article-title":"Significant treatment failure with intravitreous bevacizumab for retinopathy of prematurity","volume":"130","author":"Patel","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2025.05.008_bib8","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1097\/IAE.0000000000003249","article-title":"Clinical features and outcomes of infants with retinopathy of prematurity who fail antivascular endothelial growth factor therapy","volume":"41","author":"Xu","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.oret.2025.05.008_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.785292","article-title":"Characteristics of eyes developing retinal detachment after anti-vascular endothelial growth factor therapy for retinopathy of prematurity","volume":"10","author":"Kondo","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1016\/j.oret.2025.05.008_bib10","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/IAE.0000000000001685","article-title":"Progressive retinal detachment in infants with retinopathy of prematurity treated with intravitreal bevacizumab or ranibizumab","volume":"38","author":"Yonekawa","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.oret.2025.05.008_bib11","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/S0161-6420(01)00809-0","article-title":"Lens-sparing vitreous surgery for tractional stage 4A retinopathy of prematurity retinal detachments","volume":"108","author":"Capone","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.05.008_bib12","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1001\/archopht.122.12.1816","article-title":"Lens-sparing vitrectomy for progressive tractional retinal detachments associated with stage 4a retinopathy of prematurity","volume":"122","author":"Moshfeghi","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2025.05.008_bib13","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.ophtha.2005.03.031","article-title":"Anatomic success rate after 3-port lens-sparing vitrectomy in stage 4A or 4B retinopathy of prematurity","volume":"112","author":"Lakhanpal","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.05.008_bib14","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1001\/archophthalmol.2011.253","article-title":"Modified 23-gauge vitrectomy system for stage 4 retinopathy of prematurity","volume":"129","author":"Wu","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2025.05.008_bib15","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.ophtha.2004.05.030","article-title":"Lens-sparing vitrectomy for stage 4 retinopathy of prematurity","volume":"111","author":"Hubbard","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.05.008_bib16","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1136\/bjophthalmol-2018-312922","article-title":"Parameters affecting postoperative success of surgery for stage 4A\/4B ROP","volume":"103","author":"\u00d6zsaygili","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2025.05.008_bib17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ntt.2016.10.008","article-title":"Do anesthetics harm the developing human brain? An integrative analysis of animal and human studies","volume":"60","author":"Lin","year":"2017","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.oret.2025.05.008_bib18","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.ophtha.2021.05.031","article-title":"International Classification of Retinopathy of Prematurity, Third Edition","volume":"128","author":"Chiang","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.05.008_bib19","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1038\/s41433-020-01305-z","article-title":"Early angiographic signs of retinopathy of prematurity requiring treatment","volume":"35","author":"Lepore","year":"2021","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.oret.2025.05.008_bib20","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1136\/bjo.2008.140657","article-title":"Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study","volume":"92","author":"Kusaka","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2025.05.008_bib21","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1001\/archopht.1992.01080140140042","article-title":"Lens-sparing vitreoretinal surgery in infants","volume":"110","author":"Maguire","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2025.05.008_bib22","doi-asserted-by":"crossref","first-page":"216","DOI":"10.4103\/tjo.tjo_102_18","article-title":"Current concepts and techniques of vitrectomy for retinopathy of prematurity","volume":"8","author":"Kusaka","year":"2018","journal-title":"Taiwan J Ophthalmol"},{"key":"10.1016\/j.oret.2025.05.008_bib23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4103\/0301-4738.53050","article-title":"Functional and anatomical outcomes after primary lens-sparing pars plana vitrectomy for Stage 4 retinopathy of prematurity","volume":"57","author":"Bhende","year":"2009","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.oret.2025.05.008_bib24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3341\/kjo.2006.20.2.113","article-title":"Lens-sparing vitrectomy for stage 4 and stage 5 retinopathy of prematurity","volume":"20","author":"Yu","year":"2006","journal-title":"Korean J Ophthalmol"},{"key":"10.1016\/j.oret.2025.05.008_bib25","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ajo.2008.10.006","article-title":"Late recurrence of retinal detachment following successful vitreous surgery for stages 4B and 5 retinopathy of prematurity","volume":"147","author":"Kondo","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2025.05.008_bib26","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0002-9394(03)00190-9","article-title":"Vitreous hemorrhage in patients with high-risk retinopathy of prematurity","volume":"136","author":"Hutcheson","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2025.05.008_bib27","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/BF02080372","article-title":"\u00dcber die Wirkung von Blutinjektionen in den Glask\u00f6rper nebst Bemerkungen \u00fcber die sog. Retinitis proliferans","volume":"84","author":"Oguchi","year":"1913","journal-title":"Graefes Arhiv f\u00fcr Ophthalmologie"},{"key":"10.1016\/j.oret.2025.05.008_bib28","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/eye.2008.36","article-title":"Pathological changes in the vitreoretinal junction 1: epiretinal membrane formation","volume":"22","author":"Snead","year":"2008","journal-title":"Eye"},{"key":"10.1016\/j.oret.2025.05.008_bib29","article-title":"Pathophysiology and clinical aspects of epiretinal membrane - review","volume":"10","author":"O\u017c\u00f3g","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.oret.2025.05.008_bib30","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/00006982-200410000-00011","article-title":"Comparison of retinal outcomes after scleral buckle or lens-sparing vitrectomy for stage 4 retinopathy of prematurity","volume":"24","author":"Hartnett","year":"2004","journal-title":"Retina"},{"key":"10.1016\/j.oret.2025.05.008_bib31","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00006982-200306000-00006","article-title":"Features associated with surgical outcome in patients with stages 4 and 5 retinopathy of prematurity","volume":"23","author":"Hartnett","year":"2003","journal-title":"Retina"},{"key":"10.1016\/j.oret.2025.05.008_bib32","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/bjo-2023-323723","article-title":"Long-term surgical outcomes and prognostic factors for advanced-stage retinopathy of prematurity after vitrectomy","volume":"109","author":"Chang","year":"2024","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2025.05.008_bib33","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ophtha.2010.04.018","article-title":"Effects and complications of bevacizumab use in patients with retinopathy of prematurity: a multicenter study in Taiwan","volume":"118","author":"Wu","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.05.008_bib34","doi-asserted-by":"crossref","first-page":"e304","DOI":"10.1111\/aos.12055","article-title":"Early vitreoretinal surgery on vascularly active stage 4 retinopathy of prematurity through the preoperative intravitreal bevacizumab injection","volume":"91","author":"Xu","year":"2013","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.oret.2025.05.008_bib35","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00417-008-0786-7","article-title":"Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity","volume":"246","author":"Honda","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2025.05.008_bib36","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ajo.2013.10.002","article-title":"Efficacy of short-term postoperative perfluoro-n-octane tamponade for pediatric complex retinal detachment","volume":"157","author":"Imaizumi","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2025.05.008_bib37","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"10.1016\/j.oret.2025.05.008_bib38","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00001648-199609000-00030","article-title":"How good is that agreement?","volume":"7","author":"Byrt","year":"1996","journal-title":"Epidemiology"},{"key":"10.1016\/j.oret.2025.05.008_bib39","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.survophthal.2018.04.002","article-title":"Retinopathy of prematurity: a review of risk factors and their clinical significance","volume":"63","author":"Kim","year":"2018","journal-title":"Surv Ophthalmol"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653025002155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653025002155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T10:19:48Z","timestamp":1770805188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653025002155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2468653025002155"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2025.05.008","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk Factors for Reoperation in Vitrectomy for Stage 4A Retinopathy of Prematurity","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2025.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}